134 related articles for article (PubMed ID: 34117631)
1. Hepatic drug-metabolizing enzymes and drug transporters in Wilson's disease patients with liver failure.
Szeląg-Pieniek S; Oswald S; Post M; Łapczuk-Romańska J; Droździk M; Kurzawski M
Pharmacol Rep; 2021 Oct; 73(5):1427-1438. PubMed ID: 34117631
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic implications of impaired nuclear receptor function and dysregulated metabolism in Wilson's disease.
Wooton-Kee CR
Pharmacol Ther; 2023 Nov; 251():108529. PubMed ID: 37741465
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of Liver Fibrosis by N2 Neutrophils in Wilson's Disease.
Mi X; Song Y; Deng C; Yan J; Li Z; Li Y; Zheng J; Yang W; Gong L; Shi J
Cell Mol Gastroenterol Hepatol; 2023; 16(5):657-684. PubMed ID: 37406734
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease changes the expression and activity of hepatic drug-metabolizing enzymes and transporters in rats.
Shen Y; Liu J; Yao B; Zhang Y; Huang S; Liang C; Huang J; Tang Y; Wang X
Toxicol Lett; 2024 May; 396():36-47. PubMed ID: 38663832
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic Cholangiocarcinoma in Wilson's Disease: A Case Report.
Jang EJ; Kang SH; Kim KW
Am J Case Rep; 2024 Jan; 25():e942372. PubMed ID: 38279525
[TBL] [Abstract][Full Text] [Related]
6. Assessment and factors affecting quality of life among patients with Wilson's disease.
Zhan T; Guan Y; Sun C; Wang L; Wang Y; Li X
Sci Rep; 2024 Apr; 14(1):8636. PubMed ID: 38622213
[TBL] [Abstract][Full Text] [Related]
7. Report of the ASFA apheresis registry study on Wilson's disease.
Pham HP; Schwartz J; Cooling L; Hofmann JC; Kim HC; Morgan S; Pagano MB; Schneiderman J; Winters JL; Yamada C; Wong EC; Wu Y
J Clin Apher; 2016 Feb; 31(1):11-5. PubMed ID: 26275240
[TBL] [Abstract][Full Text] [Related]
8. Effects of Honokiol on CYP450 Activity and Transporter mRNA Expression in Type 2 Diabetic Rats.
Wang J; Zhai T; Chen Y
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534510
[TBL] [Abstract][Full Text] [Related]
9. Pregnancies in Women After Liver Transplant due to Wilson's Disease-Case Series.
Jabiry-Zieniewicz Z; Stelmach DA; Jasak K; Knap-Wielgus W; Szumska A; Raszeja-Wyszomirska J; Szpotanska-Sikorska M
Transplant Proc; 2024 May; 56(4):919-922. PubMed ID: 38729835
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced liver graft toxicity caused by cytochrome P450 poor metabolism.
Kóbori L; Kõhalmy K; Porrogi P; Sárváry E; Gerlei Z; Fazakas J; Nagy P; Járay J; Monostory K
Br J Clin Pharmacol; 2008 Mar; 65(3):428-36. PubMed ID: 18070218
[TBL] [Abstract][Full Text] [Related]
11. Maternal separation influences hepatic drug-metabolizing CYP450 gene expression without pathological changes in adult mice.
Jarrar YB; Ashour W; Madani A; Jarrar Q; Abulebdah D; Jamous YF; Labban SY; Tazkarji M
J Basic Clin Physiol Pharmacol; 2024 Jan; 35(1-2):85-91. PubMed ID: 38468541
[TBL] [Abstract][Full Text] [Related]
12. Late-Onset Wilson's Disease.
Žigrai M; Vyskočil M; Tóthová A; Vereš P; Bluska P; Valkovič P
Front Med (Lausanne); 2020; 7():26. PubMed ID: 32118011
[TBL] [Abstract][Full Text] [Related]
13. Neuromuscular Electrical Stimulation Therapy for Dysphagia Caused by Wilson's Disease.
Lee SY; Yang HE; Yang HS; Lee SH; Jeung HW; Park YO
Ann Rehabil Med; 2012 Jun; 36(3):409-13. PubMed ID: 22837979
[TBL] [Abstract][Full Text] [Related]
14.
Singh DK; Ahire D; Davydov DR; Prasad B
Drug Metab Dispos; 2024 Apr; ():. PubMed ID: 38641346
[TBL] [Abstract][Full Text] [Related]
15. Effects of intermittent fasting on the histology and mRNA expression of major drug-metabolizing cyp450s in the liver of diabetic mice.
Al-Kazimi N; Jarrar Y; Abdul-Wahab G; Alsayed AR; Madani A; Abulebdah D; Musleh RS; Jarrar Q; Al-Ameer HJ; Al-Awaida W; Abdullah E
Libyan J Med; 2023 Dec; 18(1):2270188. PubMed ID: 37883503
[No Abstract] [Full Text] [Related]
16. Analysis of risk factors for fatty liver disease in children with Wilson's disease.
Jia SP; Wang MX; Tao Z; Gao YN; Yu GR; Yang WM
Eur J Gastroenterol Hepatol; 2024 Jun; ():. PubMed ID: 38874972
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Markedly Elevated Liver Enzymes With Serendipitous Underlying Wilson's Disease With Chronic Alcohol Abuse.
Nguyen KT; Nguyen DD; Montecinos L; Hlaing PP; Khatri S
Cureus; 2024 Apr; 16(4):e59025. PubMed ID: 38803772
[TBL] [Abstract][Full Text] [Related]
18. Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.
Rendic S; Guengerich FP
Curr Drug Metab; 2010 Jan; 11(1):4-84. PubMed ID: 20302566
[TBL] [Abstract][Full Text] [Related]
19. Erratum: Novel mutations in ATP7B in Chinese patients with Wilson's disease and identification of kidney disorder of thinning of the glomerular basement membrane.
Frontiers Production Office
Front Neurol; 2023; 14():1290996. PubMed ID: 37799280
[TBL] [Abstract][Full Text] [Related]
20. 1H-NMR-based metabolomics to dissect the traditional Chinese medicine promotes mesenchymal stem cell homing as intervention in liver fibrosis in mouse model of Wilson's disease.
Ma Y; Bao Y; Wang H; Jiang H; Zhou L; Yang B; Huang X; Yang W; Xie D; Zhang J
J Pharm Pharmacol; 2024 Jun; 76(6):656-671. PubMed ID: 38429940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
